Skyhawk Therapeutics Appoints Guerciolini Chief Medical Officer

Roberto Guerciolini is now chief medical officer of Skyhawk Therapeutics. Guerciolini’s experience includes posts at Wave Life Sciences (NASDAQ: [[ticker:WVE]]), SIRNA Therapeutics, and Dicerna Pharmaceuticals (NASDAQ: [[ticker:DRNA]]). Waltham, MA-based Skyhawk is developing RNA-targeting drugs to treat cancer and neurological diseases. Skyhawk launched a little more than a year ago; last June, the company landed a partnership with Celgene (NASDAQ: [[ticker:CELG]]) and simultaneously announced a $40 million round of funding.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.